Director Jeffrey Fink resigns from Lipocine Board effective Jan 1, 2026

Lipocine Inc.

Jeffrey Fink informed the Board on Dec 12, 2025 of his resignation effective Jan 1, 2026 for personal reasons.
Resignation not due to any disagreement with the Company on any matter.
Board intends to conduct a search for a new director.

item 5.02

Lipocine Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-027744

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.